Ventyx Biosciences, Inc.(VTYX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VTYX Ventyx Biosciences, Inc.

休市中 11-15 16:00:00 EST

1.87

-0.10

-5.08%

盘后1.91

+0.04+2.13%

18:46 EST

最高2.00	最低1.87	成交量129.80万
今开2.00	昨收1.97	日振幅6.60%
总市值1.32亿	流通市值9,298万	总股本7,071万
成交额247.37万	换手率2.61%	流通股本4,972万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"VTYX","market":"US","secType":"STK","nameCN":"Ventyx Biosciences, Inc.","latestPrice":1.87,"timestamp":1731704400000,"preClose":1.97,"halted":0,"volume":1297988,"hourTrading":{"tag":"盘后","latestPrice":1.9099,"preClose":1.87,"latestTime":"18:46 EST","volume":12636,"amount":23784.626,"timestamp":1731714375865},"delay":0,"floatShares":49721386,"shares":70710667,"eps":-2.327124,"marketStatus":"休市中","marketStatusCode":7,"change":-0.1,"latestTime":"11-15 16:00:00 EST","open":2,"high":2,"low":1.87,"amount":2473724.4810248,"amplitude":0.06599,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.327124,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1731920400000},"adr":0,"listingDate":1634788800000,"adjPreClose":1.97,"preHourTrading":{"tag":"盘前","latestPrice":1.9974,"preClose":1.97,"latestTime":"09:15 EST","volume":2155,"amount":4266.569854,"timestamp":1731680137719},"postHourTrading":{"tag":"盘后","latestPrice":1.9099,"preClose":1.87,"latestTime":"18:46 EST","volume":12636,"amount":23784.626,"timestamp":1731714375865},"volumeRatio":1.2184937136153344,"impliedVol":3.4956,"impliedVolPercentile":0.9841},"requestUrl":"/m/hq/s/VTYX","defaultTab":"news","newsList":[{"id":"2483538276","title":"Ventyx Biosciences, Inc.盘中异动 股价大跌5.08%报1.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483538276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483538276?lang=zh_cn&edition=full","pubTime":"2024-11-16 04:59","pubTimestamp":1731704392,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日04时59分，Ventyx Biosciences, Inc.股票出现异动，股价快速下挫5.08%。截至发稿，该股报1.87美元/股，成交量103.958万股，换手率1.47%，振幅6.09%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为3.64%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116045952a23c0bb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116045952a23c0bb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"2481988832","title":"Ventyx Biosciences, Inc.盘中异动 早盘大幅拉升6.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481988832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481988832?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:32","pubTimestamp":1730903559,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时32分，Ventyx Biosciences, Inc.股票出现波动，股价大幅上涨6.42%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为1070.77%、100.21%、52.15%，振幅较大的相关个股有Fate Therapeutics, Inc.、Nurix Therapeutics, Inc.、Inmed Pharmaceuticals Inc.，振幅分别为107.84%、106.06%、106.04%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223239971a4bfe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223239971a4bfe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2480818252","title":"Ventyx Biosciences Inc    预计每股亏损 52 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480818252","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480818252?lang=zh_cn&edition=full","pubTime":"2024-11-02 12:05","pubTimestamp":1730520353,"startTime":"0","endTime":"0","summary":"   * Ventyx Biosciences Inc    预计在11月4日公布截至2024年9月30日的财报() 时，季度收入不会有变化。*    * LSEG分析师对Ventyx Biosciences Inc的平均预期是每股亏损52美分。* 目前分析师对该公司股票的平均评级为 \"买入\"，建议的细目为6个 \"强烈买入 \"或 \"买入\"，3个 \"持有\"，没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Ventyx Biosciences Inc 的 12 个月目标价中位数为 10.00 美元，高于其最新收盘价 2.15 美元。11月2日 - 以往季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Ventyx Biosciences Inc    预计每股亏损 52 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTYX"],"gpt_icon":0},{"id":"2479102235","title":"Ventyx Biosciences, Inc.盘中异动 股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479102235","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479102235?lang=zh_cn&edition=full","pubTime":"2024-10-30 00:23","pubTimestamp":1730219028,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日00时23分，Ventyx Biosciences, Inc.股票出现波动，股价急速上涨5.19%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030002349a1f61623&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030002349a1f61623&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2478730438","title":"Ventyx Biosciences, Inc.盘中异动 早盘股价大涨5.05%报2.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478730438","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478730438?lang=zh_cn&edition=full","pubTime":"2024-10-28 23:20","pubTimestamp":1730128803,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日23时20分，Ventyx Biosciences, Inc.股票出现异动，股价快速上涨5.05%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102823200498e3edeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102823200498e3edeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"2477635499","title":"Ventyx Biosciences, Inc.盘中异动 临近午盘急速下跌5.23%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477635499","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477635499?lang=zh_cn&edition=full","pubTime":"2024-10-22 23:42","pubTimestamp":1729611750,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日23时42分，Ventyx Biosciences, Inc.股票出现波动，股价急速跳水5.23%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为4854.40%、4375.29%、2002.54%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Genprex, Inc.、Aptevo Therapeutics Inc.，振幅分别为170.68%、101.99%、99.41%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022234230a1e2d54a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022234230a1e2d54a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2477986767","title":"Ventyx Biosciences, Inc.盘中异动 早盘大幅下跌5.09%报2.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477986767","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477986767?lang=zh_cn&edition=full","pubTime":"2024-10-21 23:17","pubTimestamp":1729523869,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日23时17分，Ventyx Biosciences, Inc.股票出现异动，股价大幅下跌5.09%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.87%。其相关个股中，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.涨幅较大，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃，换手率分别为5703.11%、3001.96%、1292.68%，振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为369.73%、157.02%、148.15%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102123174998e3d91d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102123174998e3d91d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"2476294402","title":"Ventyx Biosciences, Inc.盘中异动 股价大涨5.10%报2.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476294402","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476294402?lang=zh_cn&edition=full","pubTime":"2024-10-19 02:31","pubTimestamp":1729276300,"startTime":"0","endTime":"0","summary":"北京时间2024年10月19日02时31分，Ventyx Biosciences, Inc.股票出现波动，股价大幅上涨5.10%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241019023140a1e1c733&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241019023140a1e1c733&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2476927868","title":"Ventyx Biosciences, Inc.盘中异动 急速拉升5.39%报2.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476927868","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476927868?lang=zh_cn&edition=full","pubTime":"2024-10-17 03:31","pubTimestamp":1729107106,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日03时31分，Ventyx Biosciences, Inc.股票出现波动，股价急速上涨5.39%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101703314698e3cd79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101703314698e3cd79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"2475989398","title":"Ventyx Biosciences, Inc.盘中异动 大幅上涨5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475989398","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475989398?lang=zh_cn&edition=full","pubTime":"2024-10-14 22:05","pubTimestamp":1728914703,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日22时05分，Ventyx Biosciences, Inc.股票出现波动，股价快速上涨5.37%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101422050398e3c49f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101422050398e3c49f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2472337604","title":"Ventyx Biosciences, Inc.盘中异动 股价大跌5.19%报2.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472337604","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472337604?lang=zh_cn&edition=full","pubTime":"2024-10-01 02:17","pubTimestamp":1727720259,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日02时17分，Ventyx Biosciences, Inc.股票出现异动，股价急速下跌5.19%。截至发稿，该股报2.19美元/股，成交量65.8448万股，换手率0.93%，振幅6.32%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410010217399719da53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410010217399719da53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2469497794","title":"Ventyx Biosciences, Inc.盘中异动 快速上涨5.08%报2.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469497794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469497794?lang=zh_cn&edition=full","pubTime":"2024-09-24 22:09","pubTimestamp":1727186968,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日22时09分，Ventyx Biosciences, Inc.股票出现波动，股价大幅上涨5.08%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.73%。其相关个股中，Seelos Therapeutics, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Wave Life Sciences Ltd.涨幅较大，Seelos Therapeutics, Inc.、Silexion Therapeutics Corp、Onconetix, Inc.较为活跃，换手率分别为2637.04%、163.62%、60.81%，振幅较大的相关个股有Seelos Therapeutics, Inc.、Onconetix, Inc.、Gri Bio, Inc.，振幅分别为101.84%、42.72%、40.32%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092422092998e38aae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092422092998e38aae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"2469114942","title":"Ventyx Biosciences, Inc.股价上涨16.96% 市值涨3224.21万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469114942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469114942?lang=zh_cn&edition=full","pubTime":"2024-09-23 21:31","pubTimestamp":1727098293,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日21时31分，Ventyx Biosciences, Inc.股票出现波动，股价大幅拉升16.96%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409232131339f106f36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409232131339f106f36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2469511989","title":"BUZZ-Ventyx 因获得赛诺菲 2700 万美元投资而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2469511989","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469511989?lang=zh_cn&edition=full","pubTime":"2024-09-23 21:02","pubTimestamp":1727096562,"startTime":"0","endTime":"0","summary":"    9月23日 - ** Ventyx Biosciences   股价盘前上涨16.5%至2.66美元** 称法国制药商赛诺菲  将对Ventyx进行2700万美元的股权投资  ** 赛诺菲将购买70,601股公司的A系列无投票权可转换优先股，每股优先股最初可转换为100股普通股 - VTYX** VTYX 同意授予赛诺菲与 VTX3232 候选药物相关的某些项目的独家优先谈判权，VTX3232 正在开发用于治疗帕金森病和肥胖症等疾病。** VTX3232 属于一类药物，可以通过大脑保护屏障阻断一种叫做 NLRP3 的特定蛋白质，这种蛋白质参与炎症反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTYX"],"gpt_icon":0},{"id":"2468502549","title":"Ventyx Biosciences, Inc.盘中异动 快速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468502549","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468502549?lang=zh_cn&edition=full","pubTime":"2024-09-20 00:12","pubTimestamp":1726762325,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日00时12分，Ventyx Biosciences, Inc.股票出现波动，股价大幅拉升5.02%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.68%。其相关个股中，Exicure, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Edgewise Therapeutics, Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Portage Biotech Inc.较为活跃，换手率分别为4408.69%、869.57%、196.25%，振幅较大的相关个股有Exicure, Inc.、Galmed Pharmaceuticals Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为101.31%、78.69%、52.97%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920001205ab64a815&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920001205ab64a815&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"2467750703","title":"Ventyx Biosciences, Inc.盘中异动 股价大涨5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2467750703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467750703?lang=zh_cn&edition=full","pubTime":"2024-09-14 00:04","pubTimestamp":1726243450,"startTime":"0","endTime":"0","summary":"北京时间2024年09月14日00时04分，Ventyx Biosciences, Inc.股票出现波动，股价快速拉升5.35%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Instil Bio, Inc.涨幅较大，Windtree Therapeutics, Inc.、Immuneering Corporation、Galmed Pharmaceuticals Ltd.较为活跃，换手率分别为829.17%、401.96%、107.32%，振幅较大的相关个股有Immuneering Corporation、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Instil Bio, Inc.，振幅分别为51.75%、48.21%、45.18%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240914000411a1da3754&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240914000411a1da3754&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2462197377","title":"Ventyx Biosciences, Inc.盘中异动 快速下跌5.04%报2.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2462197377","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462197377?lang=zh_cn&edition=full","pubTime":"2024-08-27 23:18","pubTimestamp":1724771921,"startTime":"0","endTime":"0","summary":"北京时间2024年08月27日23时18分，Ventyx Biosciences, Inc.股票出现波动，股价快速下跌5.04%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240827231841ab60247a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240827231841ab60247a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VTYX","BK4007"],"gpt_icon":0},{"id":"2461597706","title":"Ventyx Biosciences, Inc.盘中异动 快速拉升5.53%报2.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461597706","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461597706?lang=zh_cn&edition=full","pubTime":"2024-08-23 22:01","pubTimestamp":1724421671,"startTime":"0","endTime":"0","summary":"北京时间2024年08月23日22时01分，Ventyx Biosciences, Inc.股票出现异动，股价快速上涨5.53%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240823220111ab5f6a4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240823220111ab5f6a4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"2461874706","title":"Ventyx Biosciences, Inc.盘中异动 快速拉升5.05%报2.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461874706","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461874706?lang=zh_cn&edition=full","pubTime":"2024-08-22 02:25","pubTimestamp":1724264711,"startTime":"0","endTime":"0","summary":"北京时间2024年08月22日02时25分，Ventyx Biosciences, Inc.股票出现波动，股价大幅拉升5.05%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082202251197199840&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082202251197199840&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0},{"id":"2460006357","title":"Ventyx Biosciences, Inc.盘中异动 急速拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460006357","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460006357?lang=zh_cn&edition=full","pubTime":"2024-08-20 02:33","pubTimestamp":1724092403,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日02时33分，Ventyx Biosciences, Inc.股票出现异动，股价急速拉升5.14%。Ventyx Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。Ventyx Biosciences, Inc.公司简介：Ventyx Biosciences Inc 是一家临床阶段的生物制药公司，专注于为数百万炎症性疾病和自身免疫性疾病患者发展新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082002332398e35684&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082002332398e35684&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VTYX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.ventyxbio.com","stockEarnings":[{"period":"1week","weight":-0.15},{"period":"1month","weight":-0.2724},{"period":"3month","weight":0.0108},{"period":"6month","weight":-0.6047},{"period":"1year","weight":-0.2076},{"period":"ytd","weight":-0.2429}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ventyx Biosciences, Inc.于2018年11月21日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，专注于为数百万患有炎症性疾病和自身免疫性疾病的患者开发新疗法。该公司相信，他们有选择性地调节关键免疫靶点以创造差异化药物的能力将使他们有可能破坏成熟的价值数十亿美元的商业市场，并使他们成为免疫学市场的领导者。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.01538},{"month":2,"riseRate":0.666667,"avgChangeRate":0.701385},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.095926},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.042289},{"month":5,"riseRate":0.666667,"avgChangeRate":0.133308},{"month":6,"riseRate":0,"avgChangeRate":-0.288909},{"month":7,"riseRate":1,"avgChangeRate":0.12313},{"month":8,"riseRate":0.333333,"avgChangeRate":0.07183},{"month":9,"riseRate":0.666667,"avgChangeRate":0.241856},{"month":10,"riseRate":0,"avgChangeRate":-0.222243},{"month":11,"riseRate":0,"avgChangeRate":-0.280464},{"month":12,"riseRate":1,"avgChangeRate":0.095095}],"exchange":"NASDAQ","name":"Ventyx Biosciences, Inc.","nameEN":"Ventyx Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ventyx Biosciences, Inc.(VTYX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ventyx Biosciences, Inc.(VTYX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ventyx Biosciences, Inc.,VTYX,Ventyx Biosciences, Inc.股票,Ventyx Biosciences, Inc.股票老虎,Ventyx Biosciences, Inc.股票老虎国际,Ventyx Biosciences, Inc.行情,Ventyx Biosciences, Inc.股票行情,Ventyx Biosciences, Inc.股价,Ventyx Biosciences, Inc.股市,Ventyx Biosciences, Inc.股票价格,Ventyx Biosciences, Inc.股票交易,Ventyx Biosciences, Inc.股票购买,Ventyx Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ventyx Biosciences, Inc.(VTYX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ventyx Biosciences, Inc.(VTYX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}